Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Different Pathological Complete Response Rates According to PAM50 Subtype in HER2+ Breast Cancer Patients Treated With Neoadjuvant Pertuzumab/Trastuzumab vs. Trastuzumab Plus Standard Chemotherapy: An Analysis of Real-World Data.
Front Oncol. 2019 Nov 5;9:1178. doi: 10.3389/fonc.2019.01178. eCollection 2019.
Front Oncol. 2019.
PMID: 31750258
Free PMC article.
Machine learning and natural language processing (NLP) approach to predict early progression to first-line treatment in real-world hormone receptor-positive (HR+)/HER2-negative advanced breast cancer patients.
Ribelles N, Jerez JM, Rodriguez-Brazzarola P, Jimenez B, Diaz-Redondo T, Mesa H, Marquez A, Sanchez-Muñoz A, Pajares B, Carabantes F, Bermejo MJ, Villar E, Dominguez-Recio ME, Saez E, Galvez L, Godoy A, Franco L, Ruiz-Medina S, Lopez I, Alba E.
Ribelles N, et al. Among authors: diaz redondo t.
Eur J Cancer. 2021 Feb;144:224-231. doi: 10.1016/j.ejca.2020.11.030. Epub 2020 Dec 26.
Eur J Cancer. 2021.
PMID: 33373867
Item in Clipboard
Significant Decrease in Annual Cancer Diagnoses in Spain during the COVID-19 Pandemic: A Real-Data Study.
Ruiz-Medina S, Gil S, Jimenez B, Rodriguez-Brazzarola P, Diaz-Redondo T, Cazorla M, Muñoz-Ayllon M, Ramos I, Reyna C, Bermejo MJ, Godoy A, Torres E, Cobo M, Galvez L, Rueda A, Alba E, Ribelles N.
Ruiz-Medina S, et al. Among authors: diaz redondo t.
Cancers (Basel). 2021 Jun 28;13(13):3215. doi: 10.3390/cancers13133215.
Cancers (Basel). 2021.
PMID: 34203185
Free PMC article.
Item in Clipboard
XENERA-1: a randomised double-blind Phase II trial of xentuzumab in combination with everolimus and exemestane versus everolimus and exemestane in patients with hormone receptor-positive/HER2-negative metastatic breast cancer and non-visceral disease.
Schmid P, Cortes J, Joaquim A, Jañez NM, Morales S, Díaz-Redondo T, Blau S, Neven P, Lemieux J, García-Sáenz JÁ, Hart L, Biyukov T, Baktash N, Massey D, Burris HA 3rd, Rugo HS.
Schmid P, et al. Among authors: diaz redondo t.
Breast Cancer Res. 2023 Jun 12;25(1):67. doi: 10.1186/s13058-023-01649-w.
Breast Cancer Res. 2023.
PMID: 37308971
Free PMC article.
Clinical Trial.
Item in Clipboard
Case Report: Propranolol increases the therapeutic response to temozolomide in a patient with metastatic paraganglioma.
Díaz-Castellanos MA, Gómez de Las Heras KV, Díaz-Redondo T, González-Flores E, Albiñana V, Botella LM.
Díaz-Castellanos MA, et al. Among authors: diaz redondo t.
F1000Res. 2017 Dec 4;6:2087. doi: 10.12688/f1000research.13185.1. eCollection 2017.
F1000Res. 2017.
PMID: 29527294
Free PMC article.
Item in Clipboard
[Teaching basic life support to the general population. Alumni intervention analysis].
Díaz-Castellanos MA, Fernández-Carmona A, Díaz-Redondo A, Cárdenas-Cruz A, García-del Moral R, Martín-Lopez J, Díaz-Redondo T.
Díaz-Castellanos MA, et al. Among authors: diaz redondo t.
Med Intensiva. 2014 Dec;38(9):550-7. doi: 10.1016/j.medin.2013.10.010. Epub 2014 Jan 31.
Med Intensiva. 2014.
PMID: 24485533
Free article.
Spanish.
Item in Clipboard
ATM Variant as a Cause of Hereditary Cutaneous Melanoma in a Spanish Family: Case Report.
Lendinez-Sanchez G, Diaz-Redondo T, Campos MI, Porta Pelayo J, Porta Pelayo JM, Muriel-López C.
Lendinez-Sanchez G, et al. Among authors: diaz redondo t.
Case Rep Oncol. 2024 Feb 27;17(1):386-391. doi: 10.1159/000536105. eCollection 2024 Jan-Dec.
Case Rep Oncol. 2024.
PMID: 38415270
Free PMC article.
Item in Clipboard
Cite
Cite